These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 32239237)
1. Long-term cost-effectiveness of screening for fracture risk in a UK primary care setting: the SCOOP study. Söreskog E; Borgström F; Shepstone L; Clarke S; Cooper C; Harvey I; Harvey NC; Howe A; Johansson H; Marshall T; O'Neill TW; Peters TJ; Redmond NM; Turner D; Holland R; McCloskey E; Kanis JA; Osteoporos Int; 2020 Aug; 31(8):1499-1506. PubMed ID: 32239237 [TBL] [Abstract][Full Text] [Related]
2. The Cost-Effectiveness of Screening in the Community to Reduce Osteoporotic Fractures in Older Women in the UK: Economic Evaluation of the SCOOP Study. Turner DA; Khioe RFS; Shepstone L; Lenaghan E; Cooper C; Gittoes N; Harvey NC; Holland R; Howe A; McCloskey E; O'Neill TW; Torgerson D; Fordham R; J Bone Miner Res; 2018 May; 33(5):845-851. PubMed ID: 29470854 [TBL] [Abstract][Full Text] [Related]
3. Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial. Shepstone L; Lenaghan E; Cooper C; Clarke S; Fong-Soe-Khioe R; Fordham R; Gittoes N; Harvey I; Harvey N; Heawood A; Holland R; Howe A; Kanis J; Marshall T; O'Neill T; Peters T; Redmond N; Torgerson D; Turner D; McCloskey E; Lancet; 2018 Feb; 391(10122):741-747. PubMed ID: 29254858 [TBL] [Abstract][Full Text] [Related]
4. A pragmatic randomised controlled trial of the effectiveness and cost-effectiveness of screening older women for the prevention of fractures: rationale, design and methods for the SCOOP study. Shepstone L; Fordham R; Lenaghan E; Harvey I; Cooper C; Gittoes N; Heawood A; Peters T; O'Neill T; Torgerson D; Holland R; Howe A; Marshall T; Kanis J; McCloskey E Osteoporos Int; 2012 Oct; 23(10):2507-15. PubMed ID: 22314936 [TBL] [Abstract][Full Text] [Related]
6. Management of Patients With High Baseline Hip Fracture Risk by FRAX Reduces Hip Fractures-A Post Hoc Analysis of the SCOOP Study. McCloskey E; Johansson H; Harvey NC; Shepstone L; Lenaghan E; Fordham R; Harvey I; Howe A; Cooper C; Clarke S; Gittoes N; Heawood A; Holland R; Marshall T; O'Neill TW; Peters TJ; Redmond N; Torgerson D; Kanis JA; J Bone Miner Res; 2018 Jun; 33(6):1020-1026. PubMed ID: 29480960 [TBL] [Abstract][Full Text] [Related]
7. Screening for high hip fracture risk does not impact on falls risk: a post hoc analysis from the SCOOP study. Condurache CI; Chiu S; Chotiyarnwong P; Johansson H; Shepstone L; Lenaghan E; Cooper C; Clarke S; Khioe RFS; Fordham R; Gittoes N; Harvey I; Harvey NC; Heawood A; Holland R; Howe A; Kanis JA; Marshall T; O'Neill TW; Peters TJ; Redmond NM; Torgerson D; Turner D; McCloskey E; Osteoporos Int; 2020 Mar; 31(3):457-464. PubMed ID: 31960099 [TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of a multifaceted intervention to improve quality of osteoporosis care after wrist fracture. Majumdar SR; Lier DA; Rowe BH; Russell AS; McAlister FA; Maksymowych WP; Hanley DA; Morrish DW; Johnson JA Osteoporos Int; 2011 Jun; 22(6):1799-808. PubMed ID: 20878389 [TBL] [Abstract][Full Text] [Related]
9. Economic evaluation of a population-based osteoporosis intervention for outpatients with non-traumatic non-hip fractures: the "Catch a Break" 1i [type C] FLS. Majumdar SR; Lier DA; Hanley DA; Juby AG; Beaupre LA; Osteoporos Int; 2017 Jun; 28(6):1965-1977. PubMed ID: 28275838 [TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of osteoporosis screening strategies for hip fracture prevention in older Chinese people: a decision tree modeling study in the Mr. OS and Ms. OS cohort in Hong Kong. Su Y; Lai FTT; Yip BHK; Leung JCS; Kwok TCY Osteoporos Int; 2018 Aug; 29(8):1793-1805. PubMed ID: 29774400 [TBL] [Abstract][Full Text] [Related]
11. A systematic review and economic evaluation of bisphosphonates for the prevention of fragility fractures. Davis S; Martyn-St James M; Sanderson J; Stevens J; Goka E; Rawdin A; Sadler S; Wong R; Campbell F; Stevenson M; Strong M; Selby P; Gittoes N Health Technol Assess; 2016 Oct; 20(78):1-406. PubMed ID: 27801641 [TBL] [Abstract][Full Text] [Related]
12. Cost-Effectiveness of Osteoporosis Interventions to Improve Quality of Care After Upper Extremity Fracture: Results From a Randomized Trial (C-STOP Trial). Majumdar SR; Lier DA; McAlister FA; Johnson JA; Rowe BH; Beaupre LA J Bone Miner Res; 2019 Jul; 34(7):1220-1228. PubMed ID: 30779861 [TBL] [Abstract][Full Text] [Related]
13. Cost-Effectiveness of the Screening for the Primary Prevention of Fragility Hip Fracture in Spain Using FRAX Martin-Sanchez M; Comas M; Posso M; Louro J; Domingo L; Tebé C; Castells X; Espallargues M Calcif Tissue Int; 2019 Sep; 105(3):263-270. PubMed ID: 31172231 [TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of two inexpensive postfracture osteoporosis interventions: results of a randomized trial. Majumdar SR; Lier DA; Leslie WD J Clin Endocrinol Metab; 2013 May; 98(5):1991-2000. PubMed ID: 23596140 [TBL] [Abstract][Full Text] [Related]
15. Clinical effectiveness and cost-effectiveness of a multifaceted podiatry intervention for falls prevention in older people: a multicentre cohort randomised controlled trial (the REducing Falls with ORthoses and a Multifaceted podiatry intervention trial). Cockayne S; Rodgers S; Green L; Fairhurst C; Adamson J; Scantlebury A; Corbacho B; Hewitt CE; Hicks K; Hull R; Keenan AM; Lamb SE; McIntosh C; Menz HB; Redmond A; Richardson Z; Vernon W; Watson J; Torgerson DJ Health Technol Assess; 2017 Apr; 21(24):1-198. PubMed ID: 28621259 [TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of pharmacological fracture prevention for osteoporosis as prescribed in clinical practice in France, Germany, Italy, Spain, and the United Kingdom. Svedbom A; Hadji P; Hernlund E; Thoren R; McCloskey E; Stad R; Stollenwerk B Osteoporos Int; 2019 Sep; 30(9):1745-1754. PubMed ID: 31270592 [TBL] [Abstract][Full Text] [Related]
17. Randomised controlled trial evaluating the effectiveness and cost-effectiveness of 'Families for Health', a family-based childhood obesity treatment intervention delivered in a community setting for ages 6 to 11 years. Robertson W; Fleming J; Kamal A; Hamborg T; Khan KA; Griffiths F; Stewart-Brown S; Stallard N; Petrou S; Simkiss D; Harrison E; Kim SW; Thorogood M Health Technol Assess; 2017 Jan; 21(1):1-180. PubMed ID: 28059054 [TBL] [Abstract][Full Text] [Related]
18. Fracture prevention by screening for high fracture risk: a systematic review and meta-analysis. Merlijn T; Swart KMA; van der Horst HE; Netelenbos JC; Elders PJM Osteoporos Int; 2020 Feb; 31(2):251-257. PubMed ID: 31838551 [TBL] [Abstract][Full Text] [Related]
19. Cost-Utility Analysis of the Ontario Fracture Screening and Prevention Program. Saunders H; Sujic R; Bogoch ER; Jain R; Jinah A; Elliot-Gibson V; Mendlowitz AB; Linton D; Inrig T; Isaranuwatchai W; Sale JEM J Bone Joint Surg Am; 2021 Jul; 103(13):1175-1183. PubMed ID: 33764937 [TBL] [Abstract][Full Text] [Related]
20. Health-related quality of life during the first year after a hip fracture: results of the Mexican arm of the International Cost and Utility Related to Osteoporotic Fractures Study (MexICUROS). Guirant L; Carlos F; Curiel D; Kanis JA; Borgström F; Svedbom A; Clark P Osteoporos Int; 2018 May; 29(5):1147-1154. PubMed ID: 29464277 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]